reference/13384060

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13384060

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	331
issn	1421-9670 0250-8095
issueIdentifier	4
pageRange	325-331
publicationName	American Journal of Nephrology
startingPage	325
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f3f80b0b7b004d8d3a2d1565261d8ae3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e5c4c3b8320300234e410cb7ed77df07
bibliographicCitation	Kanbay M, Ikizek M, Solak Y, Selcoki Y, Uysal S, Armutcu F, Eryonucu B, Covic A, Johnson RJ. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol. 2011;33(4):325–31. PMID: 21389698; PMCID: PMC3064941.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7c8db11e49ca69aebf065398cc1b3d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f865ac157524e1a9e6a64bafb74ca28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cff448c226dd3ee940241dd9da4331f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73baa05030735782621d739f79b45167 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c391489d0e929a396f41486b13b7a14f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4670beef38213243c5ec9a7a588dd66f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_640bf29741c16cdd2929d79fb73c9410 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03480fbc1741e828a9812755e3cba95c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce5eb280800520853bb1a507afc4316c
date	2011
identifier	https://pubmed.ncbi.nlm.nih.gov/21389698 https://pubmed.ncbi.nlm.nih.gov/PMC3064941 https://doi.org/10.1159/000324916
isPartOf	https://portal.issn.org/resource/ISSN/0250-8095 https://portal.issn.org/resource/ISSN/1421-9670 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/437
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Uric Acid and Pentraxin-3 Levels Are Independently Associated with Coronary Artery Disease Risk in Patients with Stage 2 and 3 Kidney Disease
discusses	http://id.nlm.nih.gov/mesh/M0208443 http://id.nlm.nih.gov/mesh/M0022340 http://id.nlm.nih.gov/mesh/M0001048 http://id.nlm.nih.gov/mesh/M0003122
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014527Q000378 http://id.nlm.nih.gov/mesh/D000683Q000096 http://id.nlm.nih.gov/mesh/D003324Q000097 http://id.nlm.nih.gov/mesh/D002097Q000096 http://id.nlm.nih.gov/mesh/D007674Q000150 http://id.nlm.nih.gov/mesh/D007674Q000097 http://id.nlm.nih.gov/mesh/D003324Q000150
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017023Q000379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D007249 http://id.nlm.nih.gov/mesh/D002097Q000378 http://id.nlm.nih.gov/mesh/D005919
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8989 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10922 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b8fb9ceda620fad83e8d5fd67981b480 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5806

Total number of triples: 66.